Publications

Peer-reviewed Research Articles

  1. R. Pedrazzani, S. Kiriakidi, M. Monari, I. Lazzarini, G. Bertuzzi, C. S. López and M. Bandini, Fluorinated Biphenyl Phosphine Ligands for Accelerated AuI-Catalysis, ACS Catalysis, 14, pp. 6128–6136, 2024

  2. S. Kiriakidi, C. Silva, R. Sanz Díez, and O. Nieto Faza, Deciphering nitroaromatics reduction: Theoretical insights into dioxomolybdenum catalysis with biomass-derived pinacol, ChemCatChem, e202301575

  3. N. Georgiou, M. G. Kakava, E. A. Routsi, E. Petsas, N. Stavridis, C. Freris, N. Zoupanou, K. Moschovou, S. Kiriakidi, and T. Mavromoustakos, Quercetin: A Potential Polydynamic Drug, Molecules, vol.28, no. 24, p. 8141, 2023

  4. I. Andreadelis, S. Kiriakidi, C. Lamprakis, et al., Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability, Journal of Physical Chemistry B, vol. 126, no. 7, pp. 1504–1519, Feb. 2022, issn: 15205207

  5. L. Xue Toro, S. Kiriakidi, A. Thapper, S. Ott, and M. Lundberg, Two routes to hydrogen evolution for a Co-polypyridyl complex with two open sites, Electronic Structure, vol. 4, no. 3, p. 034 002, Jul. 2022, issn: 2516-1075

  6. E. Chontzopoulou, C. D. Papaemmanouil, M. V. Chatziathanasiadou, et al., Molecular investigation of artificial and natural sweeteners as potential anti-inflammatory agents, Journal of Biomolecular Structure and Dynamics, vol. 40, no. 23, pp. 12 608–12 620, 2021, issn: 15380254

  7. S. Kiriakidi, C. Chatzigiannis, C. Papaemmanouil, A. G. Tzakos, Z. Cournia, and T. Mavromoustakos, Interplay of cholesterol, membrane bilayers and the AT1R: A cholesterol consensus motif on AT1R is revealed, Computational and Structural Biotechnology Journal, vol. 19, pp. 110–120, Jan. 2021, issn:2001-0370

  8. A. D. Tsiailanis, E. I. Vrettos, M. Choleva, et al., Development of a DHA-Losartan hybrid as a potent inhibitor of multiple pathway-induced platelet aggregation, Journal of Biomolecular Structure and Dynamics, vol. 40, no. 24, pp. 13 889–13 900, 2021, issn: 15380254

  9. S. Kiriakidi, C. Chatzigiannis, C. Papaemmanouil, A. G. Tzakos, and T. Mavromoustakos, Exploring the role of the membrane bilayer in the recognition of candesartan by its GPCR AT1 receptor, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol. 1862, no. 3, p. 183 142, Mar. 2020, issn:0005-2736.

  10. C. Koukoulitsa, E. Chontzopoulou, S. Kiriakidi, A. G. Tzakos, and T. Mavromoustakos, A Journey to the Conformational Analysis of T-Cell Epitope Peptides Involved in Multiple Sclerosis, Brain Sciences, 2020, Vol. 10, Page 356, vol. 10, no. 6, p. 356, Jun. 2020, issn: 2076-3425.

  11. A. D. Tsiailanis, A. Renziehausen, S. Kiriakidi, et al., Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid, Free Radical Biology and Medicine, vol. 160, pp. 391–402, Nov. 2020, issn: 0891-5849.

  12. D. Ntountaniotis, I. Andreadelis, T. F. Kellici, et al., Host-Guest Interactions between Candesartan and Its Prodrug Candesartan Cilexetil in Complex with 2-Hydroxypropyl-β-cyclodextrin: On the Biological Potency for Angiotensin II Antagonism, Molecular Pharmaceutics, vol. 16, no. 3, pp. 1255–1271, Mar. 2019, issn: 15438392.

  13. A. Konstantinidi, N. Naziris, M. Chountoulesi, et al., Comparative Perturbation Effects Exerted by the Influenza A M2 WT Protein Inhibitors Amantadine and the Spiro-pyrrolidine-2,2-adamantane Variant AK13 to Membrane Bilayers Studied Using Biophysical Experiments and Molecular Dynamics Simulations, Journal of Physical Chemistry B, vol. 122, no. 43, pp. 9877–9895, Nov. 2018, issn: 15205207.

  14. S. Kiriakidi, O. Nieto Faza, A. Kolocouris, and C. S. López, Governing effects in the mechanism of the gold-catalyzed cycloisomerization of allenic hydroxylamine derivatives, Organic Biomolecular Chemistry, vol. 15, no. 28, pp. 5920–5926, Jul. 2017, issn: 1477-0539.

Books and Chapters

  1. E. Chontzopoulou, S. Kiriakidi, P. Zoumpoulakis, and T. Mavromoustakos, Principles of Computational Chemistry. Kallipos Academic Editions, 2023.

  2. S. Kiriakidi, Z. Cournia, and T.Mavromoustakos, Effects of cholesterol on the GPCR AT1 receptor and its interplay with AT1 antagonists. Academic Press, Jan. 2022, pp. 147–168.

  3. C. M. Chatzigiannis, S. Kiriakidi, A. G. Tzakos, and T. Mavromoustakos, 2D DOSY NMR: A Valuable Tool to Confirm the Complexation in Drug Delivery Systems. Humana Press Inc., 2021, vol. 2207, pp. 235–246.

  4. S. Kiriakidi and T. Mavromoustakos, Study of Candesartan Cilexetil: 2-Hydroxypropyl-β-Cyclodextrin Interactions: A Computational Approach Using Steered Molecular Dynamics Simulations. Humana Press Inc., 2021, vol. 2207, pp. 45–70.

  5. S. Kiriakidi, A. Kolocouris, G. Liapakis, S. Ikram, S. Durdagi, and T. Mavromoustakos, Effects of cholesterol on GPCR function: Insights from computational and experimental studies. Springer New York LLC, 2019, vol. 1135, pp. 89–103.

Preprints

  1. S. Kiriakidi, C. S. López, and O. N. Faza, Three cycles in the dioxomolybdenum-catalyzed reduction of nitrobenzenes to anilines with pinacol. A computational study towards the valorization of biomass subproducts., Feb. 2023.

  2. I. Andreadelis, S. Kiriakidi, C. Lamprakis, et al., Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability, Jun. 2021.

Theses

  1. S. Kiriakidi, Applications of theoretical and biophysical studies on rational drug design, 2021

  2. S. Kiriakidi, Theoretical investigation of the hydrogen-generating mechanism of Co(py)(bpy)Cl2, 2014